Skip to content

Pressure and Diabetic Foot

Neurovascular Cutaneous Response to Pressure and Risk of Diabetic Foot Ulcer in Patients With Type 2 Diabetes

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03213093
Acronym
PIV & MPP
Enrollment
200
Registered
2017-07-11
Start date
2017-12-01
Completion date
2026-03-31
Last updated
2021-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes and Risk of Diabetic Foot Ulcer

Keywords

Diabetes, Diabetic Foot Ulcer, Plantar pressure

Brief summary

Diabetic foot ulcer (DFU) is a worldwide burden in the management of patients with diabetes. Peripheral neuropathy has a key role in the physiopathology of DFU. Others factors as skin vulnerability to plantar pressure, glycation of skin protein, articular rigidity, vascular component and abnormal foot plantar pressure are also important to take into account. The aim of the study is to assess prospectively different factors involved in DFU pathogenesis notably the neurovascular response to non noxious pressure.

Interventions

OTHERMeasure of cutaneous microcirculation

Measure of cutaneous microcirculation in response to a local application of pressure, to local heating and to the iontophoretic administration of acetylcholine

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>18 years * Type 2 diabetic subject * Absence of active diabetic foot ulcer * Patients Grade 0, Grade 1, Grade 2 or Grade 3 of the International Working Group on Diabetic Foot Risk Classification defined by: * absence of alteration of perception of Monofilament 10g at the level of the plantar arch for the grade 0 * alteration of perception of Monofilament 10g at the level of the plantar arch for the grade 1 * alteration of perception of Monofilament 10g at the level of the plantar arch associated with foot deformity and / or an arteriopathy defined by the absence of perception of one of the two peripheral pulses for the grade 2 * History of diabetic foot ulcer for the grade 3 * Signature of consent to participate in the study

Exclusion criteria

* Chronic alcoholism with usual consumption of at least 5 alcoholic drinks per day * Pregnancy * Congenital methemoglobinemia. * Porphyria * Skin injured on the tibia, whatever the lesion * Recent major cardiovascular history (less than 3 months) * Severe renal disease (serum creatinine\> 300 μmol.l-1)

Design outcomes

Primary

MeasureTime frameDescription
the rate of incidence of diabetic foot ulcerAt any time during a 3 years follow-upA diabetic foot ulcer is defined as a breakdown in the skin under malleolus

Secondary

MeasureTime frameDescription
Neurovascular response to pressureAt the end of the 3-year follow-upReceiver Operating Characteristic (ROC) analysis for neurovascular response to predict foot ulcer. Results are expressed in arbitrary unit.

Countries

France

Contacts

Primary ContactJulien Vouillarmet
julien.vouillarmet@chu-lyon.fr4-78-86-14-89

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026